Atherosclerosis  	Atherosclerosis  	 NNP	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
inflammation  	inflammation  	 JJ	B-NP
Inflammation  	Inflammation  	 NNP	I-NP
plays  	plays  	 VBZ	O
an  	an  	 DT	O
important  	important  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
atherosclerotic  	atherosclerotic  	 JJ	B-NP
vascular  	vascular  	 JJ	I-NP
disease  	disease  	 NN	I-NP
which  	which  	 WDT	O
is  	is  	 VBZ	O
the  	the  	 DT	O
leading  	leading  	 JJ	O
cause  	cause  	 NN	O
of  	of  	 IN	O
morbidity  	morbidity  	 NN	O
and  	and  	 CC	O
mortality  	mortality  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
adult  	adult  	 NN	B-NP
population 	population 	 NN	I-NP
.  	.  	 .	O
Various  	Various  	 JJ	B-NP
risk  	risk  	 NN	I-NP
factors  	factors  	 NNS	I-NP
trigger  	trigger  	 VBP	O
an  	an  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
response  	response  	 NN	I-NP
leading  	leading  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
initiation  	initiation  	 NN	O
and  	and  	 CC	O
development  	development  	 NN	O
of  	of  	 IN	O
atherosclerotic  	atherosclerotic  	 JJ	B-NP
vascular  	vascular  	 JJ	I-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
Several  	Several  	 JJ	O
adhesion  	adhesion  	 JJ	B-NP
molecules 	molecules 	 NNS	I-NP
,  	,  	 ,	O
cytokines 	cytokines 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
growth  	growth  	 NN	B-NP
factors  	factors  	 NNS	I-NP
secreted  	secreted  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
endothelium  	endothelium  	 JJ	O
aggravate  	aggravate  	 JJ	O
inflammation  	inflammation  	 NN	B-NP
and  	and  	 CC	O
increase  	increase  	 VB	O
subendothelial  	subendothelial  	 JJ	B-NP
lipid  	lipid  	 JJ	I-NP
accumulation 	accumulation 	 NN	I-NP
.  	.  	 .	O
With  	With  	 IN	O
continuing  	continuing  	 VBG	B-NP
inflammation 	inflammation 	 NN	I-NP
,  	,  	 ,	O
plaque  	plaque  	 JJ	O
rupture  	rupture  	 NN	O
occurs  	occurs  	 VBZ	O
resulting  	resulting  	 VBG	O
in  	in  	 IN	O
acute  	acute  	 JJ	O
coronary  	coronary  	 JJ	B-NP
syndromes 	syndromes 	 NN	I-NP
.  	.  	 .	O
Recently 	Recently 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
importance  	importance  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
immune  	immune  	 JJ	O
system  	system  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
mechanisms  	mechanisms  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
response  	response  	 NN	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
elucidated 	elucidated 	 NN	O
.  	.  	 .	O
One  	One  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
markers  	markers  	 NN	O
of  	of  	 IN	O
subclinical  	subclinical  	 JJ	B-NP
inflammation  	inflammation  	 NN	I-NP
in  	in  	 IN	O
atherosclerosis  	atherosclerosis  	 NN	B-NP
is  	is  	 VBZ	O
increased  	increased  	 VBN	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
high-sensitivity  	high-sensitivity  	 NNP	I-NP
CRP 	CRP 	 NNP	I-NP
.  	.  	 .	O
Several  	Several  	 JJ	O
clinical  	clinical  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
have  	have  	 VBP	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
suppression  	suppression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
response  	response  	 NN	I-NP
can  	can  	 MD	O
delay  	delay  	 VB	O
or  	or  	 CC	O
decrease  	decrease  	 VB	O
the  	the  	 DT	O
atherosclerotic  	atherosclerotic  	 JJ	B-NP
process 	process 	 NN	I-NP
.  	.  	 .	O
Among  	Among  	 IN	O
the  	the  	 DT	O
approaches  	approaches  	 NNS	O
for  	for  	 IN	O
a  	a  	 DT	O
healthier  	healthier  	 JJ	O
lifestyle 	lifestyle 	 NN	O
,  	,  	 ,	O
diets  	diets  	 JJ	O
low  	low  	 JJ	O
in  	in  	 IN	O
saturated  	saturated  	 JJ	O
fats 	fats 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
Mediterranean  	Mediterranean  	 NNP	B-NP
diet 	diet 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
exercise  	exercise  	 NN	O
have  	have  	 VBP	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
decrease  	decrease  	 VB	O
the  	the  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
response 	response 	 NN	I-NP
.  	.  	 .	O
Various  	Various  	 JJ	B-NP
pharmacologic  	pharmacologic  	 JJ	I-NP
agents  	agents  	 NNS	I-NP
also  	also  	 RB	O
have  	have  	 VB	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
effects 	effects 	 NNS	I-NP
.  	.  	 .	O
Lipid-lowering  	Lipid-lowering  	 JJ	B-NP
therapies 	therapies 	 NNS	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
particular  	particular  	 JJ	O
statins  	statins  	 NNS	B-NP
have  	have  	 VBP	O
proved  	proved  	 VBN	O
to  	to  	 TO	O
have  	have  	 VB	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
on  	on  	 IN	O
atheromatous  	atheromatous  	 JJ	B-NP
plaques 	plaques 	 NN	I-NP
.  	.  	 .	O
Several  	Several  	 JJ	O
clinical  	clinical  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
have  	have  	 VBP	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
an  	an  	 DT	O
increased  	increased  	 JJ	O
inflammatory  	inflammatory  	 JJ	B-NP
response  	response  	 NN	I-NP
benefit  	benefit  	 NN	I-NP
more  	more  	 RBR	O
from  	from  	 IN	O
statins 	statins 	 NN	B-NP
.  	.  	 .	O
Therapeutic  	Therapeutic  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
targeting  	targeting  	 VBG	O
directly  	directly  	 RB	O
the  	the  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
response  	response  	 NN	I-NP
and  	and  	 CC	O
vaccination  	vaccination  	 NN	O
against  	against  	 IN	O
atherosclerosis  	atherosclerosis  	 NNS	B-NP
are  	are  	 VBP	O
under  	under  	 IN	O
investigation 	investigation 	 NN	B-NP
.  	.  	 .	O
